Indoleamine 2,3-dioxygenase expression in patients with allergic rhinitis: a case-control study

Clinical and Translational Allergy

Volumn 1, Issue 1, 2011, Pages 1-6

  Luukkainen, Annika ^a   Karjalainen, Jussi ^b   Honkanen, Teemu ^a,c   Lehtonen, Mikko ^a,c   Paavonen, Timo ^a,b   Toppila Salmi, Sanna ^d,e  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

^c KANTA HÄME CENTRAL HOSPITAL   (Finland)

^d HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^e UNIVERSITY OF HELSINKI   (Finland)

Author keywords

allergic rhinitis; birch pollen; dendritic cell; eosinophil; Indoleamine 2,3 dioxygenase; interferon gamma; kynurenine; leukocyte; tryptophan

Indexed keywords

IMMUNOGLOBULIN E; INDOLEAMINE 2,3 DIOXYGENASE;

ADULT; ALLERGIC RHINITIS; ARTICLE; BIRCH; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; EOSINOPHIL COUNT; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOHISTOCHEMISTRY; MALE; NASAL BIOPSY; NOSE MUCOSA; POLLEN ALLERGY; PRIORITY JOURNAL;

EID: 85006253363     PISSN: None     EISSN: 20457022     Source Type: Journal    
DOI: 10.1186/2045-7022-1-17     Document Type: Article

References (29)

1. Moffett JR, Namboodiri MA: Tryptophan and the immune response. Immunol Cell Biol. 2003, 81: 247-65. 10.1046/j.1440-1711.2003.t01-1-01177.x.
2. Xu H, Oriss TB, Fei M: Indoleamine 2,3-dioxygenase in lung dendritic cells promotes Th2 responses and allergic inflammation. Proc Natl Acad Sci USA. 2008, 105: 6690-5. 10.1073/pnas.0708809105.
3. Yoshida R, Urade Y, Tokuda M, Hayaishi O: Induction of indoleamine 2,3-dioxygenase in mouse lung during virus infection. Proc Natl Acad Sci USA. 1979, 76: 4084-6. 10.1073/pnas.76.8.4084.
4. Daubener W, MacKenzie CR: IFN-gamma activated indoleamine 2,3-dioxygenase activity in human cells is an antiparasitic and an antibacterial effector mechanism. Adv Exp Med Biol. 1999, 467: 517-24. 10.1007/978-1-4615-4709-9_64.
5. von Bubnoff D, Hanau D, Wenzel J, Takikawa O, Hall B, Koch S, Bieber T: Indoleamine 2,3-dioxygenase-expressing antigen-presenting cells and peripheral T-cell tolerance: another piece to the atopic puzzle?. J Allergy Clin Immunol. 2003, 112: 854-60. 10.1016/S0091-6749(03)02014-1.
6. van der Marel AP, Samsom JN, Greuter M, van Berkel LA, O'Toole T, Kraal G, Mebius RE: Blockade of IDO inhibits nasal tolerance induction. J Immunol. 2007, 179: 894-900.
7. Chen W, Liang X, Peterson AJ, Munn DH, Blazar BR: The indoleamine 2,3-dioxygenase pathway is essential for human plasmacytoid dendritic cell-induced adaptive T regulatory cell generation. J Immunol. 2008, 181: 5396-404.
8. Taher YA, Piavaux BJ, Gras R: Indoleamine 2,3-dioxygenase-dependent tryptophan metabolites contribute to tolerance induction during allergen immunotherapy in a mouse model. J Allergy Clin Immunol. 2008, 121: 983-10.1016/j.jaci.2007.11.021. 91.e2
9. Brenk M, Scheler M, Koch S: Tryptophan deprivation induces inhibitory receptors ILT3 and ILT4 on dendritic cells favoring the induction of human CD4+CD25+ Foxp3+ T regulatory cells. J Immunol. 2009, 183: 145-54. 10.4049/jimmunol.0803277.
10. Onodera T, Jang MH, Guo Z: Constitutive expression of IDO by dendritic cells of mesenteric lymph nodes: functional involvement of the CTLA-4/B7 and CCL22/CCR4 interactions. J Immunol. 2009, 183: 5608-14. 10.4049/jimmunol.0804116.
11. Xu H, Zhang GX, Ciric B, Rostami A: IDO: a double-edged sword for T(H)1/T(H)2 regulation. Immunol Lett. 2008, 121: 1-6. 10.1016/j.imlet.2008.08.008.
12. Grohmann U, Volpi C, Fallarino F: Reverse signaling through GITR ligand enables dexamethasone to activate IDO in allergy. Nat Med. 2007, 13: 579-86. 10.1038/nm1563.
13. Hayashi T, Beck L, Rossetto C: Inhibition of experimental asthma by indoleamine 2,3-dioxygenase. J Clin Invest. 2004, 114: 270-9.
14. Gordon JR, Li F, Nayyar A, Xiang J, Zhang X: CD8 alpha+, but not CD8 alpha-, dendritic cells tolerize Th2 responses via contact-dependent and -independent mechanisms, and reverse airway hyperresponsiveness, Th2, and eosinophil responses in a mouse model of asthma. J Immunol. 2005, 175: 1516-22.
15. Maneechotesuwan K, Wamanuttajinda V, Kasetsinsombat K, Huabprasert S, Yaikwawong M, Barnes PJ, Wongkajornsilp A: Der p 1 suppresses indoleamine 2, 3-dioxygenase in dendritic cells from house dust mite-sensitive patients with asthma. J Allergy Clin Immunol. 2009, 123: 239-48. 10.1016/j.jaci.2008.10.018.
16. Forsythe P, Inman MD, Bienenstock J: Oral treatment with live Lactobacillus reuteri inhibits the allergic airway response in mice. Am J Respir Crit Care Med. 2007, 175: 561-9. 10.1164/rccm.200606-821OC.
17. Wolf AM, Wolf D, Rumpold H: Overexpression of indoleamine 2,3-dioxygenase in human inflammatory bowel disease. Clin Immunol. 2004, 113: 47-55. 10.1016/j.clim.2004.05.004.
18. Torres MI, Lopez-Casado MA, Lorite P, Rios A: Tryptophan metabolism and indoleamine 2,3-dioxygenase expression in coeliac disease. Clin Exp Immunol. 2007, 148: 419-24. 10.1111/j.1365-2249.2007.03365.x.
19. Joenvaara S, Mattila P, Renkonen J: Caveolar transport through nasal epithelium of birch pollen allergen Bet v 1 in allergic patients. J Allergy Clin Immunol. 2009, 124: 135-10.1016/j.jaci.2008.11.048. 142.e1-21
20. Paveglio SA, Allard J, Foster Hodgkins SR: Airway epithelial indoleamine 2,3-dioxygenase inhibits CD4+ T cells during Aspergillus fumigatus antigen exposure. Am J Respir Cell Mol Biol. 2011, 44: 11-23. 10.1165/rcmb.2009-0167OC.
21. von Bubnoff D, Fimmers R, Bogdanow M, Matz H, Koch S, Bieber T: Asymptomatic atopy is associated with increased indoleamine 2,3-dioxygenase activity and interleukin-10 production during seasonal allergen exposure. Clin Exp Allergy. 2004, 34: 1056-63. 10.1111/j.1365-2222.2004.01984.x.
22. Maneechotesuwan K, Supawita S, Kasetsinsombat K, Wongkajornsilp A, Barnes PJ: Sputum indoleamine-2, 3-dioxygenase activity is increased in asthmatic airways by using inhaled corticosteroids. J Allergy Clin Immunol. 2008, 121: 43-50. 10.1016/j.jaci.2007.10.011.
23. Araujo E, Palombini BC, Cantarelli V, Pereira A, Mariante A: Microbiology of middle meatus in chronic rhinosinusitis. Am J Rhinol. 2003, 17: 9-15.
24. Dai X, Zhu BT: Indoleamine 2,3-dioxygenase tissue distribution and cellular localization in mice: implications for its biological functions. J Histochem Cytochem. 2010, 58: 17-28. 10.1369/jhc.2009.953604.
25. Ball HJ, Sanchez-Perez A, Weiser S: Characterization of an indoleamine 2,3-dioxygenase-like protein found in humans and mice. Gene. 2007, 396: 203-13. 10.1016/j.gene.2007.04.010.
26. Metz R, Duhadaway JB, Kamasani U, Laury-Kleintop L, Muller AJ, Prendergast GC: Novel tryptophan catabolic enzyme IDO2 is the preferred biochemical target of the antitumor indoleamine 2,3-dioxygenase inhibitory compound D-1-methyl-tryptophan. Cancer Res. 2007, 67: 7082-7. 10.1158/0008-5472.CAN-07-1872.
27. Lob S, Konigsrainer A, Zieker D, Brucher BL, Rammensee HG, Opelz G, Terness P: IDO1 and IDO2 are expressed in human tumors: levo- but not dextro-1-methyl tryptophan inhibits tryptophan catabolism. Cancer Immunol Immunother. 2009, 58: 153-7. 10.1007/s00262-008-0513-6.
28. Busse WW: The role of allergy in disease. Immunol Rev. 2011, 242: 5-9. 10.1111/j.1600-065X.2011.01036.x.
29. An XJ, Bai CX, Xia JB, Dang T, Qian P, Qian GS, Liao W: Immature dendritic cells expressing indoleamine 2, 3-dioxygenase suppress ovalbumin-induced allergic airway inflammation in mice. J Investig Allergol Clin Immunol. 2011, 21: 185-92.